Pasquale Patrone

Pasquale Patrone

Auto-generated profile, based on publicly available information

Pasquale Patrone

Institute of Dermatology, Department of Experimental and Clinical Medicine, University of Udine, San Michele Hospital, Piazza Rodolone 1, Gemona del Friuli, 33013 Udine, Italy

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2014 in The Scientific World Journal
Verified
Journal Article
Open access
PDF file
GSGiuseppe Stinco
Giuseppe Stinco
MRMaurizio Ruscio
Maurizio Ruscio
SBSerena Bergamo
Serena Bergamo
DTDavide Trotter
Davide Trotter
PPPasquale Patrone
Pasquale Patrone
Background. Lyme Borreliosis is a multisystemic infection caused by spirochetes ofBorrelia burgdorferi sensu latocomplex. The features of Lyme Borreliosis may differ in the various geographical areas, primarily between the manifestations found in America and those found in Europe and Asia.Objective. to describe the clinical features of Lyme Borreliosis in an endemic geographic area such as Friuli-Venezia Giulia in the Northeastern part of Italy.Methods. The medical records of patients resulted seropositive forBorrelia burgdorferihave been retrospectively recorded and analyzed.Results. Seven hundred and five patients met the inclusion criteria, 363 males and 342 females. Erythema migrans was the most common manifestation, detected in 437 patients. Other classical cutaneous manifestations included 58 cases of multiple erythema migrans, 7 lymphadenosis benigna cutis, and 18 acrodermatitis chronica atrophicans. The musculoskeletal system was involved in 511 patients. Four hundred and sixty patients presented a neurological involvement. Flu-like symptoms preceded or accompanied or were the only clinical feature in 119 patients.Comments. The manifestations of Lyme borreliosis recorded in this study are similar to the ones of other endemic areas in Europe, even if there are some peculiar features which are different from those reported in Northern Europe and in the USA.

23 September 2013 in Dermatology Research and Practice
Verified
Journal Article
Open access
PDF file
GSGiuseppe Stinco
Giuseppe Stinco
CBCinzia Buligan
Cinzia Buligan
EEEnzo Errichetti
Enzo Errichetti
FVFrancesca Valent
Francesca Valent
PPPasquale Patrone
Pasquale Patrone
Psoriasis is considered to be an inflammatory autoimmune disease, where angiogenesis plays an undefined pathogenetic role. The well-known changes of the superficial microvasculature in the psoriatic plaque can be easily assessed in vivo by videocapillaroscopy. In the last years, several studies reported the clinical and capillaroscopic response of the psoriatic plaque during different topical and systemic treatments. In the present work we evaluated the effects of acitretin (0.8 mg/kg/day) on videocapillaroscopic alterations and the clinical response in 11 patients affected by plaque psoriasis at the baseline (T0) and after 4 (T1), 8 (T2), and 12 (T3) weeks. A clinical improvement during the treatment with a complete clinical healing of the plaque in 7 of the 11 patients was observed. The typical “basket-weave” capillaries of the psoriatic lesions showed a reduction of 65.4% in diameter at the end of the study; only 3 patients returned to a normal capillaroscopic pattern. As observed during previous our studies, we found a discrepancy between clinical and capillaroscopic results, with a far greater improvement in the first than in the second. This finding could be in agreement with a secondary role of blood vessels in the pathogenesis and persistence of psoriatic lesions.

18 December 2002 in International Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
PPPasquale Patrone
Pasquale Patrone
GBGiovanni Bragadin
Giovanni Bragadin
VFVincenzo De Francesco
Vincenzo De Francesco
AFAlfonsina Frattasio
Alfonsina Frattasio
GSGiuseppe Stinco
Giuseppe Stinco

18 August 2014 in Case Reports in Dermatological Medicine
Verified
Journal Article
Open access
PDF file
Enzo ErrichettiEnzo Errichetti
Enzo Errichetti
GSGiuseppe Stinco
Giuseppe Stinco
EPEnrico Pegolo
Enrico Pegolo
NMNicola di Meo
Nicola di Meo
GTGiusto Trevisan
Giusto Trevisan
PPPasquale Patrone
Pasquale Patrone
Seborrheic pemphigoid (SP), first described in 1969 by Schnyder, is a peculiar variant of BP which clinically resembles pemphigus erythematosus, since it is characterized by ruptured bullae and erosions covered with crusts involving the seborrheic areas. To the best of our knowledge, from the first description only four other cases of SP have been reported, of which two are in the English literature. We report an additional case of SP in a 56-year-old man with cervical spondylogenic myelopathy with very impaired mobility.

4 May 2007
Verified
Closed access
GSGiuseppe Stinco
Giuseppe Stinco
FPFabio Piccirillo
Fabio Piccirillo
VFVincenzo De Francesco
Vincenzo De Francesco
PPPasquale Patrone
Pasquale Patrone